AGR2 Antibody [AGR2105] | 33-010

AGR2 Antibody [AGR2105] | 33-010 | Gentaur UK, US & Europe Distribution

Host: Mouse

Reactivity: Human, Mouse

Homology: N/A

Immunogen: A recombinant protein fragment from the N-terminal region of human AGR2 was used as the immunogen for this antibody.

Research Area: Cancer, Cell Cycle

Tested Application: WB, IHC

Application: Western blot: 4-8 ug/ml
IHC (FFPE) : 3-5 ug/ml
Provided assay concentrations are suggestions only, AGR2 antibody titration may be required for optimal results.

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Protein G affinity chromatography

Clonality: Monoclonal

Clone: AGR2105

Isotype: IgG1, kappa

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.1 mg/ml BSA and 0.05% sodium azide

Concentration: 0.5 mg/mL

Storage Condition: Aliquot and Store at -20˚C. Avoid freez-thaw cycles.

Alternate Name: AGR2 Antibody: AG2, GOB-4, HAG-2, XAG-2, PDIA17, HEL-S-116, AG2, UNQ515/PRO1030, Anterior gradient protein 2 homolog, HPC8, AG-2

User Note: Optimal dilutions for each application to be determined by the researcher

BACKGROUND: AGR2 (Anterior gradient protein 2 homolog) is thought to promote breast tumorigenesis and is overexpressed in breast cancer cells. High levels of AGR2 indicate a poor prognosis. This suggests it may serve as a useful prognostic indicator and marker of breast cancer metastasis.